查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829327

2025年全球药物释放型球囊导管市场报告

Drug Eluting Balloons Catheters Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物释放型球囊导管市场规模迅速扩张，从2024年的14.3亿美元成长到2025年的16.5亿美元，复合年增长率为15.4%。预测期内的增长可归因于呼吸系统疾病的增多、药物洗脱球囊导管优于传统吸入器的优势、患者对药物洗脱球囊导管的偏好、政府在呼吸健康方面的倡议、战略联盟与伙伴关係关係、药物製剂的进步以及老年人口的增长。

预计未来几年药物释放型球囊导管市场将快速成长，到2029年将达到26.2亿美元，复合年增长率为12.2%。预测期内增长的主要驱动因素包括呼吸系统疾病的持续增长、老年人口的增长、认知度和教育水平的提高、新兴国家的市场扩张、定製药物配方、监管支持和合规性以及包装和设计的创新。预测期内的主要趋势包括智慧吸入器及其连接性、向呼吸驱动吸入器的转变、关注儿科和老年患者的需求、生技药品的输送以及环保的吸入器设计。

药物释放型球囊导管是一种用于经经皮冠状动脉介入治疗 (PCI) 治疗冠状动脉疾病的医疗设备。它们是半相容血管成形术球囊，表面涂有抗增生药物。在球囊充气过程中，药物会释放到血管壁，防止血管再阻塞并降低晚期血栓症的风险，且无需植入永久性异物。

药物释放型球囊导管主要用于治疗冠状动脉疾病和周边血管疾病。用于治疗冠状动脉疾病的药物释放型球囊导管采用亲油性基质，将抗增殖药物直接输送至血管壁，无需使用金属人工替代物或不可降解聚合物等永久性结构。导管可使用多种药物，包括紫杉醇和Sirolimus，导管由尼龙和聚氨酯等材料製成。导管广泛应用于医院、诊所、门诊手术中心和导管室。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在寻求透过双重采购关键零件、增加标准产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告提供药物释放型药物释放型容器的市场统计数据，包括全球市场规模、区域份额、药物释放型球囊容器市场份额竞争对手、药物释放型球囊容器的详细细分市场、市场趋势和商机，以及在药物释放型球囊容器行业取得成功所需的数据。本研究报告提供了药物释放型球囊容器市场的所有信息，并对该行业的现状和未来趋势进行了深入分析。

未来五年预测成长率为12.2%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自法国和义大利等主要地区的紫杉醇涂层技术和球囊扩张控制器征收关税直接影响美国，从而可能导致周边动脉疾病的治疗选择减少，介入放射学费用上升。此外，透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响将更为广泛。

预计週边和心血管疾病的日益普及将推动未来药物释放型球囊导管市场的成长。心血管疾病 (CVD) 包括多种​​影响心臟和循环系统的疾病，而周边动脉疾病(PAD) 则具体涉及动脉狭窄，主要导致流向手臂和腿部的血流减少。药物释放型球囊导管用于治疗冠状动脉疾病 (CAD)，其特征是半相容血管成形术用气球，涂有抗增殖药物，一旦进入血管即可发挥抗血管再阻塞作用。例如，美国政府机构美国疾病管制与预防中心 (CDC) 在 2024 年 5 月报告称，心臟病将在 2022 年导致 702,880 人死亡，占总死亡人数的五分之一。美国每年约有80.5万人心臟病发作，其中约60.5万人为首次心臟病发作，20万人曾罹患心臟病。因此，週边和心血管疾病的盛行率不断上升，推动了药物释放型球囊导管市场的发展。

微创手术需求的不断增长预计将进一步推动药物释放型球囊导管市场的成长。微创手术切口小，癒合时间更快，疼痛更少，感染风险更低。药物释放型球囊在这些治疗中至关重要，它透过将药物直接输送到治疗部位来防止血管再阻塞并提高血管干预的有效性。例如，Intuitive Surgical Inc. 报告称，使用其 Vinci 手术系统的手术数量将从 2021 年的 1,594,000 例增加 18%，到 2022 年将达到 1,875,000 例。此外，美国整形外科医师协会指出，到 2022 年，美国的微创美容手术数量将增加到 23,672,269 例。因此，微创手术需求的不断增长正在推动药物释放型球囊导管市场的成长。

为了确保竞争优势，药物释放型球囊导管市场的主要参与者正在加紧开发配备先进技术的下一代产品。例如，2024年3月，美国生物医学和生物技术工程公司波士顿科学宣布其AGENT药物涂层球囊（DCB）已获得美国食品药物管理局（FDA）的核准。本产品是美国第一个专门用于治疗支架内血管再阻塞（ISR）的药物涂层冠状动脉球囊。 AGENT DCB采用紫杉醇涂层，可输送治疗剂量，有效降低ISR復发，无需额外支架或放射治疗。临床试验显示，不利事件发生率低，标靶部位心臟病发作风险降低49%。

2023年6月，Translumina Therapeutics公司收购了Blue Medical Devices BV，收购金额未揭露。这项策略性收购旨在将Blue Medical专有的药物输送技术整合到Translumina的产品线中，扩大其神经血管和周边介入产品线，并增强其药物输送能力。 Blue 医疗设备 BV是一家总部位于荷兰的医疗器材製造商，专门生产药物释放型球囊导管。

药物释放型球囊导管市场包括依Everolimus和 Stellarex 的销售。该市场的价值为“出厂价”，即产品製造商或创造者销售的产品价值，无论是销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物释放型球囊导管：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球药物释放型球囊导管市场：成长率分析
  • 全球药物释放型球囊导管市场表现：规模与成长，2019-2024
  • 全球药物释放型球囊导管市场预测：规模与成长，2024-2029年，2034年
  • 全球药物释放型球囊导管：总目标市场（TAM）

第六章 市场细分

  • 全球药物释放型球囊导管市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 用于治疗冠状动脉疾病的药物释放型球囊导管
  • 用于治疗週边血管疾病的药物释放型球囊导管
  • 全球药物释放型球囊导管市场（依药物、实际及预测）2019-2024 年、2024-2029 年、2034 年
  • 紫杉醇
  • Sirolimus
  • 其他药物
  • 全球药物释放型球囊导管市场：依材料、实际结果及预测，2019-2024 年、2024-2029 年、2034 年
  • 尼龙
  • 聚氨酯
  • 其他成分
  • 全球药物释放型球囊导管市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 门诊手术中心
  • 导管室
  • 全球药物释放型球囊导管市场：依冠状动脉疾病（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型球囊导管
  • 一般球囊导管
  • 全球药物释放型球囊导管市场：依週边血管疾病（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型球囊导管
  • 血管成形术用气球导管
  • 全球药物释放型球囊导管市场：血管成形术用气球导管细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型血管成形术用气球导管

第七章 区域和国家分析

  • 全球药物释放型球囊导管市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球药物释放型球囊导管市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 药物释放型球囊导管市场：竞争格局
  • 药物释放型球囊导管市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • B Braun Melsungen Aktiengesellschaft
  • Terumo Corporation
  • Cook Medical LLC
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Acotec Scientific Co. Ltd.
  • Cordis Corporation
  • Biosensors International Group Ltd.
  • Zylox-Tonbridge Medical Technology Co. Ltd.
  • Mermaid Medical AS
  • Hexacath Limited
  • Zhejiang Barty Medical Technology Co. Ltd.
  • Cardionovum GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年药物释放型球囊导管市场：提供新机会的国家
  • 2029年药物释放型球囊导管市场：细分市场带来新机会
  • 2029年药物释放型球囊导管市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27948u

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.62 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs.

The forecast of 12.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on paclitaxel-coating technologies and balloon expansion controllers, sourced from key regions such as France and Italy, which could lead to reduced peripheral artery disease treatment options and higher interventional radiology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of peripheral and cardiovascular diseases is anticipated to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that diminishes blood flow mainly to the arms or legs. Drug-eluting balloon catheters are utilized in the treatment of coronary artery disease (CAD); they feature a semi-compliant angioplasty balloon coated with an anti-proliferative agent that exerts an anti-restenotic effect upon entering the vessel. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, heart disease was responsible for 702,880 deaths, representing 1 in every 5 fatalities. Annually, around 805,000 individuals in the United States suffer a heart attack, with approximately 605,000 being their first heart attack and 200,000 occurring in those who have previously experienced one. Thus, the rising prevalence of peripheral and cardiovascular diseases is propelling the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Subsegments:
  • 1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters; Plain Balloon Catheters
  • 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Angioplasty Balloon Catheters
  • 3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation; B Braun Melsungen Aktiengesellschaft; Terumo Corporation; Cook Medical LLC; Lepu Medical Technology Co. Ltd.; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; BIOTRONIK SE & Co. KG; Acotec Scientific Co. Ltd.; Cordis Corporation; Biosensors International Group Ltd.; Zylox-Tonbridge Medical Technology Co. Ltd.; Mermaid Medical AS; Hexacath Limited; Zhejiang Barty Medical Technology Co. Ltd.; Cardionovum GmbH; Nano Therapeutics Pvt. Ltd.; Tokai Medical Products Inc.; Opto Circuits Limited; Acrostak (Schweiz) AG; Machine Solutions Inc.; Concept Medical Inc.; Aachen Resonance GmbH; AR Baltic Medical UAB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Eluting Balloons Catheters Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Eluting Balloons Catheters Market Growth Rate Analysis
  • 5.4. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM)

6. Drug Eluting Balloons Catheters Market Segmentation

  • 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Artery Disease Drug-Eluting Balloon Catheters
  • Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nylon
  • Polyurethane
  • Other Raw Materials
  • 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • 6.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Balloon Catheters
  • Plain Balloon Catheters
  • 6.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Balloon Catheters
  • Angioplasty Balloon Catheters
  • 6.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Angioplasty Balloon Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Angioplasty Balloon Catheters

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Eluting Balloons Catheters Market

  • 9.1. China Drug Eluting Balloons Catheters Market Overview
  • 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Eluting Balloons Catheters Market

  • 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

  • 11.1. Japan Drug Eluting Balloons Catheters Market Overview
  • 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

  • 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

  • 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

  • 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

  • 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

  • 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

  • 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Eluting Balloons Catheters Market

  • 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

  • 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

  • 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

  • 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

  • 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

  • 23.1. North America Drug Eluting Balloons Catheters Market Overview
  • 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

  • 24.1. USA Drug Eluting Balloons Catheters Market Overview
  • 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

  • 25.1. Canada Drug Eluting Balloons Catheters Market Overview
  • 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

  • 26.1. South America Drug Eluting Balloons Catheters Market Overview
  • 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

  • 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

  • 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

  • 29.1. Africa Drug Eluting Balloons Catheters Market Overview
  • 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
  • 30.2. Drug Eluting Balloons Catheters Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • 31.1. B Braun Melsungen Aktiengesellschaft
  • 31.2. Terumo Corporation
  • 31.3. Cook Medical LLC
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Meril Life Sciences Pvt. Ltd.
  • 31.6. MicroPort Scientific Corporation
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. Acotec Scientific Co. Ltd.
  • 31.9. Cordis Corporation
  • 31.10. Biosensors International Group Ltd.
  • 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
  • 31.12. Mermaid Medical AS
  • 31.13. Hexacath Limited
  • 31.14. Zhejiang Barty Medical Technology Co. Ltd.
  • 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

34. Recent Developments In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Eluting Balloons Catheters Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Balloons Catheters Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Balloons Catheters Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer